Prince Pharmaceutical Co., Ltd. (TPEX:6935)

Taiwan · Delayed Price · Currency is TWD

28.40

-0.05 (-0.18%)

Mar 6, 2026, 1:28 PM CST

Revenue by Segment

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Health Food Products Department	554.46M	492.78M	494.24M	327.79M	196.47M
Health Food Products Department Growth	12.52%	-0.30%	50.78%	66.84%	41.12%
Western Medicine Section	135.57M	260.55M	218.29M	113.29M	99.33M
Western Medicine Section Growth	-47.97%	19.36%	92.68%	14.06%	-10.02%
Joint	1.30M	1.16M	221.00K	-	-
Joint Growth	12.01%	423.53%	-	-	-
Total	691.32M	754.48M	712.75M	441.08M	295.79M
Total Growth	-8.37%	5.86%	61.59%	49.12%	18.50%

Revenue by Geography

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Taiwan	620.75M	619.47M	594.93M	391.53M	250.19M
Taiwan Growth	0.21%	4.13%	51.95%	56.49%	26.35%
Japan	55.74M	95.62M	70.74M	35.20M	39.75M
Japan Growth	-41.71%	35.16%	100.97%	-11.45%	-19.63%
Other Countries	5.03M	33.75M	3.88M	1.92M	5.85M
Other Countries Growth	-85.11%	768.98%	101.98%	-67.13%	173.80%
Singapore	8.52M	4.49M	-	-	-
Singapore Growth	89.86%	-	-	-	-
South Korea	-	-	42.97M	12.42M	-
South Korea Growth	-	-	245.95%	-	-
Total	690.03M	753.33M	712.53M	441.08M	295.79M
Total Growth	-8.40%	5.73%	61.54%	49.12%	18.50%

Source: S&P Global Market Intelligence.